IQVIA™ Real-World Insights Bibliography

Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Author(s): Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1)
Affiliations(s): 1) IQVIA Solutions Japan KK, Tokyo Japan
Publication(s):  Value & Outcomes Spotlight
Document Type(s): Article,
Countries: Japan, USA,
Click here for the abstract
C:
Y:
Mental health,
2023
  L:
A:
English
Database Study, Observational study, Retrospective database analysis,
  Add to report
 
 
Prevalence of subjective memory complaints: Population study in Spain
Author(s): Javier González García a∗, Eva García Aguilar a, Tatiana Vilchez Quinoa, Marta Blanco b and Carmen Barrull b
Affiliations(s): a Departamento Médico, ITF Research Pharma, SLU, Alcobendas, Madrid, España b IQVIA España, Barcelona, España
Publication(s):  Revista Española de Geriatría y Gerontología
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Mental health, Neurological disorders,
2023
  L:
A:
Spanish
  Add to report
 
 
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons
Author(s): Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4)
Affiliations(s): 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan 2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 3) Health and Value, Pfizer Japan Inc., Tokyo, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publication(s):  The Journal of Dermatology
Document Type(s): Article,
Countries: Japan,
Click here for the abstract
C:
Y:
Dermatology, Mental health,
2022
  L:
A:
English
Patient questionnaire, Quality of life, Survey research,
  Add to report
 
 
Factors and their weight in reducing life expectancy in schizophrenia
Author(s): Correll CU, Bitter I, Hoti F, Mehtälä J, Wooller A, Pungor K, Tiihonen J
Affiliations(s): 1.The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany. Electronic address: ccorrell@northwell.edu. 2.Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. 3.EPID Research, Finland (an IQVIA company). 4.Janssen, Medical Affairs EMEA, High Wycombe, United Kingdom. 5.Janssen-Cilag, Medical Affairs EMEA, Dusseldorf, Germany. 6.Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden; Neuroscience Center, Helsinki, Finland.
Publication(s):  Schizophr Res. 2022 Nov 8;250:67-75.
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Mental health,
2022
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Observational study,
  Add to report
 
 
Prevalence of depression in Japan and the US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Author(s): Demiya S 1, Takeno S 1, Kim SW 2, Lee WS 3, Sakai Y 1 (rwesheorj 1-3)
Affiliations(s): 1) IQVIA Solutions Japan, Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, 13, Japan 3) IQVIA Solutions Japan, Tokyo, 12, Japan
Publication(s):  ISPOR Europe
Document Type(s): Conference, Poster, Presentation,
Countries: Japan, USA,
Click here for the abstract
C:
Y:
Mental health,
2022
  L:
A:
English
Database Study, Retrospective database analysis,
  Add to report
 
 
Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia
Author(s): Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C
Affiliations(s): Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS
Publication(s):  Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993.
Document Type(s): Article,
Countries: Italy, USA,
Click here for the abstract
C:
Y:
Mental health, Metabolic Disorders ,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany
Author(s): Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Palao D, Roca M, Volz HP
Affiliations(s): Kasper S: Center for Brain Research, Medical University of Vienna, Austria; Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., RWS
Publication(s):  Int J Psychiatry Clin Pract. 2021 Sep 20:1-10. doi: 10.1080/13651501.2021.1972120. Epub ahead of print. PMID: 34543170.
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Mental health,
2021
  L:
A:
English
Clinical setting: Primary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue
Author(s): Brad Millson, G Sarah Power, Dr. Roger S. McIntyre
Affiliations(s): Brad Millson, G Sarah Power, IQVIA RWE team
Publication(s):  CADTH 2020
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes, Mental health,
2020
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study
Author(s): Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  BMJ
Document Type(s): Article,
Countries: Finland, Nordic,
Click here for the abstract
C:
Y:
Mental health,
2019
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Trends in Psychotropic Medication Use for Canadian Children and Youth with ASD from 2010 to 2016: A Pharmacoepidemiologic Study
Author(s): McMorris, C.A.1, Patten, S.2, Stewart, D.3, Tehrani, A.3 & Pringsheim, T.2
Affiliations(s): 1 Werklund School of Education, University of Calgary (Calgary, AB Canada) 2 Cumming School of Medicine, University of Calgary (Calgary, AB Canada)
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Mental health,
2019
  L:
A:
English
Database Study,
  Add to report
 
 
 1 of 26 Next Page Last Page